Clinical manifestations and typing of drug-induced liver injury
10.3969/j.issn.1001-5256.2021.11.004
- VernacularTitle:药物性肝损伤的临床表现和分型
- Author:
Wanna YANG
1
;
Wen XIE
1
Author Information
1. Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
- Publication Type:Discussions by experts
- Keywords:
Chemical and Drug-Induced Liver Injury;
Clinical Feature;
Pathogenesis;
Phenotypes
- From:
Journal of Clinical Hepatology
2021;37(11):2525-2529
- CountryChina
- Language:Chinese
-
Abstract:
Drug-induced liver injury (DILI) is one of the most common and severe adverse drug reactions in humans, which may lead to liver failure and even death in some patients. Liver injury caused by different drugs has various clinical manifestations and severities, and most patients with DILI have no symptoms or have mild symptoms. There are various typing methods for DILI based on clinical features, course of disease, and pathogenesis. According to the R value, DILI can be classified into hepatocellular injury type (R ≥5), cholestasis type (R ≤2), and mixed type (2 < R < 5); according to the course of the disease, DILI can be classified into acute DILI and chronic DILI; according to the pathogenesis, DILI can be classified into intrinsic DILI, idiosyncratic DILI, and indirect DILI. A comprehensive understanding of the clinical manifestations and typing methods of DILI helps to reveal its pathogenesis and perform diagnosis and treatment in a timely manner.
